PNC Financial Services Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $760K | Buy |
4,042
+42
| +1% | +$8.09K | ﹤0.01% | 1433 |
|
|
2025
Q4 | $757K | Hold |
4,000
| – | – | ﹤0.01% | 1407 |
|
|
2025
Q3 | $663K | Hold |
4,000
| – | – | ﹤0.01% | 1474 |
|
|
2025
Q2 | $613K | Hold |
4,000
| – | – | ﹤0.01% | 1423 |
|
|
2025
Q1 | $629K | Hold |
4,000
| – | – | ﹤0.01% | 1377 |
|
|
2024
Q4 | $628K | Hold |
4,000
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q3 | $710K | Hold |
4,000
| – | – | ﹤0.01% | 1327 |
|
|
2024
Q2 | $674K | Hold |
4,000
| – | – | ﹤0.01% | 1331 |
|
|
2024
Q1 | $665K | Hold |
4,000
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q4 | $661K | Hold |
4,000
| – | – | ﹤0.01% | 1350 |
|
|
2023
Q3 | $623K | Hold |
4,000
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q2 | $624K | Hold |
4,000
| – | – | ﹤0.01% | 1408 |
|
|
2023
Q1 | $648K | Hold |
4,000
| – | – | ﹤0.01% | 1378 |
|
|
2022
Q4 | $639K | Hold |
4,000
| – | – | ﹤0.01% | 1371 |
|
|
2022
Q3 | $564K | Hold |
4,000
| – | – | ﹤0.01% | 1439 |
|
|
2022
Q2 | $584K | Sell |
4,000
-999
| -20% | -$149K | ﹤0.01% | 1448 |
|
|
2022
Q1 | $810K | Sell |
4,999
-46
| -0.9% | -$7.45K | ﹤0.01% | 1362 |
|
|
2021
Q4 | $956K | Sell |
5,045
-160
| -3% | -$30.9K | ﹤0.01% | 1301 |
|
|
2021
Q3 | $1.05M | Buy |
5,205
+80
| +2% | +$16.8K | ﹤0.01% | 1166 |
|
|
2021
Q2 | $1.03M | Sell |
5,125
-2
| -0% | -$372 | ﹤0.01% | 1179 |
|
|
2021
Q1 | $900K | Hold |
5,127
| – | – | ﹤0.01% | 1210 |
|
|
2020
Q4 | $869K | Sell |
5,127
-75
| -1% | -$12.4K | ﹤0.01% | 1183 |
|
|
2020
Q3 | $843K | Hold |
5,202
| – | – | ﹤0.01% | 1117 |
|
|
2020
Q2 | $848K | Buy |
5,202
+2
| +0% | +$304 | ﹤0.01% | 1106 |
|
|
2020
Q1 | $666K | Buy |
5,200
+4,000
| +333% | +$539K | ﹤0.01% | 1144 |
|
|
2019
Q4 | $167K | Hold |
1,200
| – | – | ﹤0.01% | 2180 |
|
|
2019
Q3 | $142K | Hold |
1,200
| – | – | ﹤0.01% | 2343 |
|
|
2019
Q2 | $155K | Sell |
1,200
-200
| -14% | -$24.7K | ﹤0.01% | 2308 |
|
|
2019
Q1 | $180K | Sell |
1,400
-300
| -18% | -$37.9K | ﹤0.01% | 2200 |
|
|
2018
Q4 | $188K | Hold |
1,700
| – | – | ﹤0.01% | 2096 |
|
|
2018
Q3 | $231K | Sell |
1,700
-101
| -6% | -$13.1K | ﹤0.01% | 2115 |
|
|
2018
Q2 | $216K | Sell |
1,801
-150
| -8% | -$17.7K | ﹤0.01% | 2135 |
|
|
2018
Q1 | $234K | Sell |
1,951
-204
| -9% | -$25.6K | ﹤0.01% | 2079 |
|
|
2017
Q4 | $268K | Buy |
2,155
+1
| +0% | +$128 | ﹤0.01% | 2018 |
|
|
2017
Q3 | $289K | Hold |
2,154
| – | – | ﹤0.01% | 1939 |
|
|
2017
Q2 | $271K | Buy |
2,154
+54
| +3% | +$6.51K | ﹤0.01% | 1968 |
|
|
2017
Q1 | $251K | Hold |
2,100
| – | – | ﹤0.01% | 2002 |
|
|
2016
Q4 | $227K | Sell |
2,100
-100
| -5% | -$10.9K | ﹤0.01% | 2050 |
|
|
2016
Q3 | $253K | Buy |
2,200
+100
| +5% | +$11.4K | ﹤0.01% | 1951 |
|
|
2016
Q2 | $214K | Sell |
2,100
-42
| -2% | -$4.48K | ﹤0.01% | 2035 |
|
|
2016
Q1 | $222K | Sell |
2,142
-100
| -4% | -$10.4K | ﹤0.01% | 2036 |
|
|
2015
Q4 | $284K | Buy |
2,242
+142
| +7% | +$17.4K | ﹤0.01% | 1860 |
|
|
2015
Q3 | $240K | Buy |
2,100
+400
| +24% | +$52.9K | ﹤0.01% | 2014 |
|
|
2015
Q2 | $229K | Buy |
1,700
+100
| +6% | +$13.3K | ﹤0.01% | 2129 |
|
|
2015
Q1 | $207K | Sell |
1,600
-50
| -3% | -$6.28K | ﹤0.01% | 2216 |
|
|
2014
Q4 | $190K | Buy |
1,650
+50
| +3% | +$5.63K | ﹤0.01% | 2106 |
|
|
2014
Q3 | $169K | Hold |
1,600
| – | – | ﹤0.01% | 2097 |
|
|
2014
Q2 | $152K | Sell |
1,600
-678
| -30% | -$60.8K | ﹤0.01% | 2052 |
|
|
2014
Q1 | $207K | Sell |
2,278
-100
| -4% | -$9.72K | ﹤0.01% | 1877 |
|
|
2013
Q4 | $211K | Buy |
2,378
+600
| +34% | +$50.2K | ﹤0.01% | 1845 |
|
|
2013
Q3 | $147K | Buy |
1,778
+578
| +48% | +$45.4K | ﹤0.01% | 1983 |
|
|
2013
Q2 | $82K | Buy |
+1,200
| New | +$83.5K | ﹤0.01% | 2201 |
|
Other funds holding BBH
MIM
CCA
BFG
PNC Financial Services Group's BBH Position: Q1 2026 in Review
PNC Financial Services Group increased its VanEck Biotech ETF (BBH) stake by 1.1% in Q1 2026, buying an estimated $8.09K and bringing the position to 4,042 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.
PNC Financial Services Group first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.05M in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- PNC Financial Services Group held 4,042 shares of VanEck Biotech ETF worth $760K as of Q1 2026.
- PNC Financial Services Group bought 42 VanEck Biotech ETF shares in Q1 2026, an estimated $8.09K.
- VanEck Biotech ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #1433 holding.
- PNC Financial Services Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- PNC Financial Services Group's VanEck Biotech ETF position peaked at $1.05M in Q3 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.